A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
2020 · Journal of Hepatology · 4,137 citations
https://doi.org/10.1016/j.jhep.2020.03.039
J
Jörn M. Schattenberg
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
804
Papers
31.8K
Citations
78
h-index
255
i10-index
Jörn M. Schattenberg is an academic researcher from Institut für Sozialforschung und Sozialwirtschaft. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Diet, Metabolism, and Disease. The author has an h-index of 78, co-authored 684 publications.
ORCID: 0000-0002-4224-4703Papers by this author
worksModeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
2018 · Journal of Hepatology · 1,933 citations
https://doi.org/10.1016/j.jhep.2018.05.036
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2024 · New England Journal of Medicine · 1,494 citations
https://doi.org/10.1056/nejmoa2309000
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
2020 · Gastroenterology · 956 citations
https://doi.org/10.1053/j.gastro.2020.01.043
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
2016 · The American Journal of Gastroenterology · 861 citations
https://doi.org/10.1038/ajg.2016.453
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat